rentosertib
PulseAugur coverage of rentosertib — every cluster mentioning rentosertib across labs, papers, and developer communities, ranked by signal.
- 2026-07-07 research_milestone Insilico Medicine's AI-discovered drug rentosertib has advanced to Phase III clinical trials for idiopathic pulmonary fibrosis. source
2 day(s) with sentiment data
-
First AI-designed drug Rentosertib enters Phase III trials
The first drug designed with significant AI involvement, Rentosertib, has advanced to Phase III clinical trials. AI was utilized to identify the drug's target, generate its molecular structure, and assist in the trial d…
-
AI News Roundup: Claude Opus 5 Benchmark, ChatGPT Adoption, and Regulatory Moves
Several AI developments are making headlines, including Anthropic's Claude Opus 5 achieving a new benchmark record on ARC-AGI-3. Meanwhile, OpenAI's ChatGPT is seeing widespread adoption by employees for tasks beyond th…
-
Insilico Medicine advances AI-discovered drug rentosertib to Phase III trials for IPF
Insilico Medicine is moving its AI-discovered drug, rentosertib, into Phase III clinical trials for idiopathic pulmonary fibrosis (IPF). The drug, which targets the TNIK protein, showed promising results in Phase II tri…
-
Takeda partners with Insilico Medicine for $600M AI drug discovery deal
Takeda Pharmaceutical Company has entered into a strategic collaboration with Insilico Medicine, utilizing AI for early-stage drug discovery. The deal, potentially worth up to US$600 million, grants Takeda exclusive wor…